Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 41Terminated 21Recruiting 12Unknown 9Active not recruiting 9Withdrawn 5Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 3Other solid neoplasm 1Other hematologic neoplasm 1

Conditions

COVID-19 2Breast Neoplasms 2Solid Tumor 1Peripheral Nervous System Diseases 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Hydroxychloroquine × Clear all
NCT04379492 2025-05-16

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

Memorial Sloan Kettering Cancer Center

Phase 2 Withdrawn

COVID-19

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

University of Arizona

Phase 2 Withdrawn
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Medical College of Wisconsin

Phase 1 Withdrawn
BreastOther solid neoplasm

Solid Tumor

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT03400254 2020-04-28

GLACIER

Abramson Cancer Center at Penn Medicine

Phase 1/2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡